2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Poster Session

[P13] Poster Session 13 Genitourinary Cancer(Urinary tract Cancer)

[P13-2] KEYNOTE-992: Pembrolizumab(pembro)+Chemoradiotherapy(CRT) Versus Placebo+CRT for Muscle-Invasive Bladder Cancer(MIBC)

Nicholas D. James1, Jeff M. Michalski2, Andrew James Weickhardt3, Michiel Simon Van Der Heijden4, Arjun Valant Balar5, Shahrokh F. Shariat6, Xiao Fang7, Ekta Kapadia7, Neal D. Shore8 (1.Institute of Cancer Research, The Royal Marsden Hospital NHS Foundation Trust, 2.Washington University School of Medicine in St. Louis, 3.Olivia Newton-John Cancer Wellness & Research Centre, 4.Netherlands Cancer Institute, 5.Perlmutter Cancer Center, NYU Langone Health, 6.Medical University of Vienna, 7.Merck & Co., Inc., 8.Carolina Urologic Research Center)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password